As of 31 Dec 2025, 9 institutional investors reported holding 45,976 shares of RIGEL PHARMACEUTICALS INC COM - Stock (RIGL).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 45,976 | $1,969,112 | +$566,127 | $42.83 | 9 |
| 2025 Q3 | 32,800 | $929,202 | +$902,186 | $28.33 | 5 |
| 2025 Q2 | 958 | $17,925 | +$791 | $18.71 | 4 |
| 2025 Q1 | 918 | $15,931 | -$4,877 | $17.99 | 5 |
| 2024 Q4 | 1,211 | $20,369 | +$8,056 | $16.82 | 5 |
| 2024 Q3 | 733 | $11,844 | +$8,579 | $16.09 | 4 |
| 2024 Q2 | 1,962 | $2,312 | -$163,645,566 | $1.48 | 5 |
| 2024 Q1 | 110,993,915 | $164,247,829 | +$6,461,700 | $1.48 | 113 |
| 2023 Q4 | 106,558,416 | $154,507,811 | +$571,013 | $1.45 | 109 |
| 2023 Q3 | 106,260,617 | $114,759,921 | -$5,306,571 | $1.08 | 103 |
| 2023 Q2 | 110,630,750 | $142,714,025 | -$2,533,807 | $1.29 | 115 |
| 2023 Q1 | 112,573,198 | $148,616,120 | +$4,899,820 | $1.32 | 120 |
| 2022 Q4 | 111,699,977 | $167,540,454 | -$26,479,106 | $1.50 | 112 |
| 2022 Q3 | 130,203,176 | $153,626,150 | -$9,564,016 | $1.18 | 128 |
| 2022 Q2 | 139,141,194 | $157,225,724 | -$32,274,101 | $1.13 | 125 |
| 2022 Q1 | 135,335,927 | $405,651,161 | -$6,980,767 | $2.99 | 156 |
| 2021 Q4 | 138,068,033 | $365,918,172 | -$5,551,667 | $2.65 | 155 |
| 2021 Q3 | 137,534,538 | $499,369,059 | -$15,438,055 | $3.63 | 156 |
| 2021 Q2 | 141,589,310 | $614,477,242 | -$9,023,051 | $4.34 | 153 |
| 2021 Q1 | 144,190,276 | $493,099,540 | +$14,137,759 | $3.42 | 143 |
| 2020 Q4 | 139,935,027 | $489,636,692 | -$3,978,227 | $3.50 | 143 |
| 2020 Q3 | 139,772,900 | $335,455,321 | -$9,169,355 | $2.40 | 134 |
| 2020 Q2 | 144,937,283 | $265,225,752 | -$7,152,731 | $1.83 | 130 |
| 2020 Q1 | 147,046,053 | $229,340,565 | +$2,082,100 | $1.56 | 119 |
| 2019 Q4 | 147,989,909 | $316,181,399 | +$493,329 | $2.14 | 130 |
| 2019 Q3 | 147,541,439 | $275,898,105 | -$7,247,695 | $1.87 | 125 |
| 2019 Q2 | 150,520,197 | $392,468,063 | +$2,233,338 | $2.61 | 123 |
| 2019 Q1 | 155,330,071 | $399,199,695 | -$7,650,214 | $2.57 | 125 |
| 2018 Q4 | 158,586,253 | $364,735,919 | +$1,162,078 | $2.30 | 128 |
| 2018 Q3 | 156,569,656 | $502,597,206 | -$699,283 | $3.21 | 133 |
| 2018 Q2 | 157,884,774 | $446,818,370 | +$53,319,447 | $2.83 | 127 |
| 2018 Q1 | 138,516,375 | $490,351,916 | +$7,661,454 | $3.54 | 115 |
| 2017 Q4 | 136,053,307 | $527,883,127 | +$104,900,267 | $3.88 | 119 |
| 2017 Q3 | 109,148,547 | $278,154,838 | -$989,820 | $2.54 | 103 |
| 2017 Q2 | 109,473,608 | $299,394,235 | +$3,755,558 | $2.73 | 104 |
| 2017 Q1 | 108,008,689 | $356,538,451 | +$88,638,159 | $3.31 | 97 |
| 2016 Q4 | 88,257,859 | $210,053,839 | -$2,676,256 | $2.38 | 101 |
| 2016 Q3 | 86,779,431 | $318,471,765 | +$17,942,977 | $3.67 | 118 |
| 2016 Q2 | 83,708,410 | $186,661,511 | +$5,010,623 | $2.23 | 114 |
| 2016 Q1 | 81,214,367 | $168,910,696 | -$6,041,147 | $2.08 | 114 |
| 2015 Q4 | 81,806,443 | $247,873,515 | +$5,712,964 | $3.03 | 119 |
| 2015 Q3 | 79,724,310 | $196,932,054 | +$2,266,996 | $2.47 | 116 |
| 2015 Q2 | 78,823,208 | $253,013,345 | +$6,365,016 | $3.21 | 120 |
| 2015 Q1 | 75,843,045 | $270,750,317 | +$4,150,254 | $3.57 | 108 |
| 2014 Q4 | 75,988,256 | $172,432,939 | -$5,979,226 | $2.27 | 89 |
| 2014 Q3 | 78,702,624 | $152,680,075 | +$1,246,057 | $1.94 | 99 |
| 2014 Q2 | 77,278,776 | $280,453,847 | -$1,659,035 | $3.63 | 98 |
| 2014 Q1 | 77,414,406 | $300,210,906 | -$5,179,731 | $3.88 | 108 |